1. Home
  2. VOR vs STK Comparison

VOR vs STK Comparison

Compare VOR & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$19.18

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Columbia Seligman Premium Technology Growth Fund Inc

STK

Columbia Seligman Premium Technology Growth Fund Inc

N/A

Current Price

$42.66

Market Cap

921.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VOR
STK
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
921.0M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
VOR
STK
Price
$19.18
$42.66
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $39.00
N/A
AVG Volume (30 Days)
★ 636.5K
51.8K
Earning Date
10-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.21
$33.38
52 Week High
$26.00
$58.46

Technical Indicators

Market Signals
Indicator
VOR
STK
Relative Strength Index (RSI) 48.50 27.28
Support Level $17.62 $38.43
Resistance Level $20.11 $53.92
Average True Range (ATR) 1.29 2.09
MACD -0.09 -0.61
Stochastic Oscillator 44.48 1.13

Price Performance

Historical Comparison
VOR
STK

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.

Share on Social Networks: